By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cytoo will coordinate a project announced on Monday that aims to combine high-throughput applications of RNAi with Cytoo's new cell normalization technology.

As part of the project, being funded with €4 million ($5.3 million) over three years under the European Commission's Seventh Framework Programme, Cytoo will partner with Cenix BioScience, Bioquant/Heidelberg University, École Polytechnique Fédérale de Lausanne, and Institute FTMC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.